The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle

Guillermo Carvajal Alegria1, Sara Boukhlal2, Divi Cornec1

  • 1Univ Brest, Inserm, CHU de Brest, LBAI, UMR1227, Brest, France; Service de Rhumatologie, Centre de Référence Maladies Autoimmunes Rares CERAINO, CHU Cavale Blanche, Brest, France.

Autoimmunity Reviews
|September 17, 2020
PubMed

Insights

Polymyalgia rheumatica (PMR) is a common condition in those over 50. Recent research highlights aging, B cell changes, and IL-6

Area of Science:

  • Rheumatology
  • Immunology
  • Gerontology

Background:

  • Polymyalgia rheumatica (PMR) is a prevalent rheumatic disease affecting individuals over 50.
  • While often linked to giant cell arteritis (GCA), PMR can occur independently.
  • The underlying pathophysiology of PMR remains incompletely understood.

Purpose of the Study:

  • To synthesize current knowledge on PMR pathophysiology.
  • To review data from genetic, immunogenetic, immunologic, antibody, and aging studies.
  • To identify gaps in current understanding and suggest future research directions.

Main Methods:

  • Literature review of existing studies on PMR pathophysiology.
  • Analysis of data related to genetics (HLA system, HLA-DRB1), immunogenetics (interleukins like IL-6), and immunology (CD8+ T cells, B cell homeostasis).
  • Inclusion of recent findings on the role of aging and cellular infiltration.

Main Results:

  • Established associations include the HLA-DRB1 gene and elevated IL-6 levels.
  • Recent studies reveal the significance of B cell homeostasis disturbances and IL-6 secretion by the innate immune system.
  • Aging emerges as a critical factor, potentially influencing susceptibility to infections, immune modulation, and hormonal changes.

Conclusions:

  • PMR pathophysiology involves complex interactions including genetic predisposition, immune dysregulation, and the aging process.
  • Further research is needed to elucidate the role of cellular infiltration around joints.
  • Understanding these factors is crucial for developing effective therapeutic strategies for PMR.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
269
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
226
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
288
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
144
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
304